Pretraživanje
Prikaz rezultata 1-10 od 23
Potential drug–drug interactions associated with clinical and laboratory findings at hospital admission
(Springer, 2020)
Background Drug–drug interactions represent one of the causes of adverse therapy outcomes through deteriorated efficacy or safety. However, the true extent of harm related to drug–drug interactions is not well established ...
The association of clopidogrel and 2-oxo-clopidogrel plasma levels and the 40 months clinical outcome after primary PCI
(Springer, Dordrecht, 2018)
Background A significant number of ischemic events occur even when adhering to dual antiplatelet therapy including aspirin and clopidogrel. Objectives The aim of our study was to determine predictors of long-term patient ...
Failure mode and effects analysis: a useful tool for prospective risk assessment in community pharmacies
(Springer, Dordrecht, 2018)
Application of clinical pharmacokinetics to optimize amikacin dosing regimen in neonates
(Springer, Dordrecht, 2012)
Drug use before and during pregnancy in Serbia
(Springer, Dordrecht, 2012)
Background Observation of drug use patterns during pregnancy is necessary for the recognition of potential bad practices and improvement of safe drug use in pregnancy. Objective To investigate prescription and over the ...
Patients' knowledge of pen-insulin therapy
(Springer, 2013)
Do we inform/educate patients well about warfarin therapy?
(Springer, 2013)
Medical doctors' perceptions of the role of clinical pharmacists in Serbian hospitals
(Springer, Dordrecht, 2013)
The influence of age, gender and comedication on lamotrigine clearance in patients with epilepsy
(Springer, Dordrecht, 2013)